A detailed history of Point72 (Difc) LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 2,669 shares of RARE stock, worth $134,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,669
Previous 10,052 73.45%
Holding current value
$134,597
Previous $469 Million 76.63%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$37.42 - $51.61 $276,271 - $381,036
-7,383 Reduced 73.45%
2,669 $110 Million
Q1 2024

May 15, 2024

BUY
$43.02 - $53.69 $432,437 - $539,691
10,052 New
10,052 $469 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.53B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.